Friday, Feb 21, 2025 · SEC filings
What the smart money revealed on Feb 21
1,042 insider filings came in. We hid 89 planned (10b5-1) sellers and 772 people whose filings were routine, like grants and tax withholding.
Solid Biosciences (SLDB) Director Joseph Edelman bought $20.1M
5M shares on the open market. Not a grant or an option exercise.
CompoSecure (GPGI) Director John Cote bought $3.86M
233,070 shares on the open market. Not a grant or an option exercise.
Charles River Laboratories International (CRL) Chairman James Foster bought $1M
6,075 shares on the open market. Not a grant or an option exercise.
Allegion (ALLE) Director Gregg Sengstack bought $1M
8,000 shares on the open market. Not a grant or an option exercise.
Astera Labs (ALAB) Officer Sanjay Gajendra sold $31.4M
Not marked as a planned 10b5-1 sale. Sold 13% of the shares they held directly. Still holds 2.35M shares.
Lucky Strike Entertainment (LUCK) Executive Vice Chairman Brett Parker sold $20.2M
Not marked as a planned 10b5-1 sale. Sold 78% of the shares they held directly. Still holds 498,092 shares.
Procore Technologies (PCOR) Director William Griffith sold $110K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 28 more real buys
Show 127 more real sales
13F season
Holdings as of Dec 31, 2024 were due Feb 14
81 funds have filed. 58 filed for the quarter before.
Biggest real insider buys, Feb 15–21
Open-market buys by officers and directors, filed in the 7 days up to Feb 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.